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Accumulating evidence has shown that microRNAs are involved in multiple processes in cancer
development and progression. Here, we report that expression of miR-625 is signiﬁcantly down-reg-
ulated and negatively correlated with lymph nodemetastasis in gastric cancer. miR-625 signiﬁcantly
inhibits invasion and metastasis of gastric cancer cells both in vitro and in vivo. Moreover, we iden-
tify that ILK is a direct target gene for miR-625 and knockdown of ILK has a phenocopy of overex-
pression of miR-625. Taken together, our ﬁndings suggest that miR-625 plays an important role in
the mechanism of tumor metastasis.
 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Gastric cancer is one of the most common malignancies and
ranks the second highest in the mortality rate worldwide [1].
Although the gastric cancer research has made great progress to
date, the molecular mechanism underlying gastric cancer is not
fully understood yet [2].
MicroRNAs (miRNAs) are short endogenous non-coding RNAs
that silence protein expression by interacting with the 30-UTRs of
their target gene mRNAs. Recent studies have demonstrated that
miRNAs can function as tumor suppressors or oncogenes in various
cancers [3]. It has been conﬁrmed that the development and pro-
gression of gastric cancer may be attributed to miRNAs [4–8]. In
our previous work, by comparing the miRNA expression proﬁle
in 28 gastric cancer tissues and their adjacent non-tumor tissues,
we found numerous putative miRNAs of differential expression
[9,10]. Of them in addition to the well-known miRNAs, such as
miR-375, miR-29c, miR-31, miR-199-3p, miR-409-3p [11] and
miR-200 family, we noticed that miR-625 was rarely researched
and was one of the most signiﬁcantly down-regulated miRNAs in
gastric cancer. In the current study, we validate the differentialchemical Societies. Published by E
.cn (B. Liu).expression of miR-625 in gastric cancer and found that miR-625
was associated with lymphatic metastasis of human gastric cancer.
Furthermore, we identify that miR-625 can regulate the invasion
and metastasis of gastric cancer cells by targeting directly the inte-
grin-linked kinase (ILK) gene product.
2. Materials and methods
2.1. Tissue samples and cell lines
Preparation of tissue samples, gastric cell lines, immortalized
normal gastric mucosal epithelial cell line (GES-1) and Human
embryonic kidney cell line 293T (HEK 293T) was described in [9].
Tissue preparation and analysis were approved by the Institutional
Review Board (IRB) of SJTU School of Medicine. Declaration of Hel-
sinki was implemented. The seven gastric cell lines and GES-1 cells
were grown in RPMI-1640, while HEK 293T was grown in DMEM
(Sigma, St Louis, MO, USA) with 10% fetal bovine serum (FBS) at
37 C in a humidiﬁed atmosphere with 5% CO2.
2.2. RNA isolation and qRT-PCR
Total RNAs were extracted from tissue samples or cell lines
using Trizol Agent (Invitrogen, Carlsbad, CA) according to thelsevier B.V. All rights reserved.
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assessed by the TaqMan stem-loop RT-PCR method with a mirVana
miRNA Detection Kit and gene-speciﬁc primers (Applied Biosys-
tems, Foster city, CA). The U6 small nuclear RNA (RNU6B; Applied
Biosystems) was used for normalization. The relative expression
ratio of miR-625 in each paired tumor and non-tumor tissue was
calculated by the 2DDCT method. For detection of ILK and GAPDH
transcript levels, cDNA was prepared from total RNA using the
SuperScript III First-Strand Synthesis System (Invitrogen, Carlsbad,
CA, USA), and subsequently quantiﬁed by SYBR Green real time RT-
PCR (Applied Biosystems) using oligonucleotides. The mRNA
expression levels of ILK were normalized using GAPDH mRNA lev-
els. Primers of ILK for qRT-PCR were as follows: F 50-CCTGCAC-
TATGCCTGTTTTTGG-30, R 50-TGTGTCCTTGTATGGAATACGGT-30.
2.3. Transient transfection
Oligonucleotides hsa-miR-625 mimics (miR-625), negative con-
trol (miR-control), hsa-miR-625 inhibitors (anti-miR-625), inhibi-
tor negative control (anti-miR-control) and siRNA for ILK were
purchased from GenePharma (Shanghai, PR China). Transfection
of cells with oligonucleotides was performed using Lipofectamine
2000 Reagent (Invitrogen, Carlsbad, CA, USA) at a ﬁnal concentra-
tion of 100 nM. Transfection efﬁciency was monitored by qRT-PCR.
2.4. Wound-healing assay
A wound-healing assay was used to assess capacity for tumor
cell motility. Brieﬂy, cells (1  106/well) were seeded in six-well
plates, cultured overnight, and transfected with miR-625 mimics
or inhibitors and the respective controls. On reaching conﬂuency,
the cell layer was scratched with a sterile plastic tip and then
washed with culture medium twice and cultured again for up to
48 or 72 h with serum-reduced medium containing 1% FBS. Photo
images of the plates were taken under a microscope. The gap clo-
sure was measured at 48 or 72 h and the data were summarized
based on sextuple assays for each experiment.
2.5. Migration and invasion assays
We used a Transwell insert (24-well insert, pore size 8 lm;
Corning, Inc., Corning, NY) to determine the effect of miR-625 on
gastric cancer cell migration and invasion in vitro. Brieﬂy, the
transfected cells were ﬁrst starved in serum-free medium over-
night, and 3  104 cells were resuspended in serum-free medium
and placed in the top chambers in triplicate. The lower chamber
was ﬁlled with 10% FBS as the chemoattractant and incubated for
48 h for the migration assay and 72 h for the invasion assay. For
the invasion assay, the inserts were previously coated with extra-
cellular matrix gel (BD Biosciences, Bedford, MA). At the end of the
experiments, the cells on the upper surface of the membrane were
removed, and the cells on the lower surface were ﬁxed and stained
with 0.1% crystal violet. Five visual ﬁelds of each insert were ran-
domly chosen and counted under a light microscope.
2.6. Retrovirus production
As previously described [11], retrovirus was prepared and
infected SGC-7901 cells for stable miR-625 expression (RV-miR-
625). Negative control was empty vector (vector). miR-625 expres-
sion was conﬁrmed by qRT-PCR.
2.7. Metastasis assay in vivo
SGC-7901 cells (1  106 cells/mouse) stably transfected with
RV-miR-625 or vector were subcutaneously injected into 6-week-old male BALB/C-nu/nu nude mice (Shanghai Laboratory Animal
Center of China) through the tail vein. The mice were raised for
60 days following injection, and tumors were measured every four
days. Then, the mice were euthanised and the lungs were dissected
and examined histologically. All animal studies complied with pro-
tocols approved by the Committee on Animal Care in Shanghai Jiao
Tong University School of Medicine.
2.8. Construction of the reporter gene system containing ILK 30UTR
The 30-UTRs of eight putative genes were synthesized according
to a 50 bp genomic fragment containing the predicted miR-625
binding sites. The mutant ILK 30-UTR construct was designed to
mutate three intermittent nucleotides complementary to the
miR-625 seed-region. Both strands were annealed and cloned into
the SpeI-MluI sites of the pMIR-REPORT miRNA expression repor-
ter vector (Applied Biosystems).
2.9. Luciferase activity assay
The 293T cells were cultured in 24-well plates and transfected
with 0.2 lg of either wide-type or mutant pMIR/ILK plasmid con-
taining ﬁreﬂy luciferase, together with 0.01 lg of the pRL-TK vec-
tor (Promega, Wisconsin, USA) containing renilla luciferase and
1 lg oligonucleotides. Transfection was performed using Lipofect-
amine 2000 reagent (Invitrogen). Relative luciferase activity was
calculated 36 h post-transfection by the Dual Luciferase Reporter
Assay (Promega).
2.10. Immunoblot analysis
ILK protein levels were quantiﬁed by standard immunoblot pro-
cedures, using rabbit anti-human ILK antibody (Bioworld, Atlanta,
Georgia, USA). Protein levels were normalized to total GAPDH,
using a rabbit monoclonal anti-GAPDH antibody (Abcam, UK).
2.11. Immunohistochemistry
Detection of ILK (Bioworld, Atlanta, Georgia, USA; dilution
1:1000) was performed on 5 mm parafﬁn sections with the indi-
cated antibodies, Peroxidase/DAB, Rabbit/Mouse (Dako, Denmark),
according to the manufacturer’s procedure. The nuclei were coun-
terstained with hematoxylin.
2.12. Statistical analysis
Data are presented as mean ± SEM. The relationship between
the miR-625 expression levels and clinicopathologic parameters
were analyzed using the Pearson Chi-square test, as well as the
relationship between miR-625 and ILK protein levels in tissues.
When comparisons were made between two different groups, sta-
tistical signiﬁcance was determined using the Student’s t test. Cor-
relation analysis was performed with non-parametric Spearman’s
rank correlation test. All statistical analyses were performed using
SPSS15.0 software (SPSS Inc., USA). A two-tailed value of p < 0.05
was considered to indicate a statistically signiﬁcant result.
3. Results
3.1. miR-625 is aberrantly down-regulated in gastric cancer tissues
and is inversely associated with lymph node metastasis
Previous microarray results showed that miR-625 is signiﬁ-
cantly down-regulated in gastric cancer. To conﬁrm these results,
quantitative real-time RT-PCR (qRT-PCR) analysis was performed
in 54 coupled samples of gastric cancer. We found that 88.24%
Table 1
miR-625 expression and clinicopathological features in gastric cancer patients.
Clinicopathologic parameters miR-625 expression p-value
Low (n = 36) Mid/High (n = 18)
Age (years)
660 14 12 0.054
>60 22 6
Gender
Male 23 13 0.540
Female 13 5
Differentiation
High, middle 12 8 0.425
Low 24 10
Location
Distal third 11 5 0.833
Middle third, proximal third 25 13
Local invasion
T1, T2 5 3 1.000
T3, T4 31 15
Lymph node metastasis
No 7 9 0.020
Yes 29 9
TNM stage
I, II 12 8 0.425
III, IV 24 10
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miR-625 compared with adjacent non-tumor tissues (1.74 ± 0.11
vs 4.37 ± 0.10, p < 0.001; Fig. 1A). Similarly, we found that expres-
sion of miR-625 was much less in seven gastric cancer cell lines
than that of immortalized normal gastric mucosal epithelial cell
line GES-1 (Fig. 1B).
To further elucidate the relationship between expression levels
of miR-625 and clinicopathologic features in gastric cancer, 54 pa-
tients with gastric cancer were analyzed. The cases were divided
into miR-625 low-expression group (n = 36) and mid/high-expres-
sion group (n = 18), based on miR-625 expression of tumor/non-
tumor < or >0.5. The miR-625 low-expression group exhibited sig-
niﬁcantly higher lymph node metastasis rate (p = 0.020). However,
the miR-625 expression levels did not show any relationship with
age, gender, tumor differentiation, tumor location, local invasion
and TNM stage (Table 1).
3.2. Ecptopic miR-625 inhibits the migration and invasion of gastric
cancer cells in SGC-7901 and MKN-45 cells
Based on the above results, we detected whether miR-625 can
change the capacity of gastric cancer cells formigration and invasion.
SGC-7901andMKN-45cellswere selected for restorationofmiR-625
using transient gene transfection. As expected, transfection of miR-
625 mimics into SGC-7901 cells resulted in substantially increase
of miR-625 expression compared with negative control (NC) trans-
fected cells (Supplementary Fig. S1). As shown in Fig. 2A, tumor cells
with miR-625 restoration slowly closed the scratch wounds com-
pared with the control (38.35 ± 0.35% vs 56.25 ± 0.25%, p = 0.006).
Moreover, the cell migration and invasion assay showed that miR-
625 restoration resulted in reduced migration rate (2.63 ± 0.10-fold,
p = 0.007) and invasion rate (3.03 ± 0.14-fold, p = 0.005) of SGC-7901
cells compared with the control (Fig. 2B). Similar results were ob-
served in MKN-45 cells (Supplementary Fig. S2 and S3).
3.3. Knockdown of miR-625 promotes the migration and invasion of
GES-1 and NCI-N87 cells
To knock down expression of miR-625, high-expressed GES-1
and NCI-N87 cells were selected for treatment with miR-625 inhib-
itors (anti-miR-625) and inhibitors negative control (anti-NC)
(Supplementary Fig. S4). In contrast, knockdown of miR-625 in
GES-1 cells resulted in signiﬁcant closer gap in wound-healing as-
say (94 ± 0.97% vs 42.5 ± 0.55%, p = 0.006) and reduction of cell
migration (2.38 ± 0.04-fold, p = 0.001)and invasion (1.99 ± 0.09-
fold, p = 0.005) in transwell assays compared with anti-NC
(Fig. 2C and 2D). Similar results were observed in NCI-N87 cells
(Supplementary Fig. S5 and S6). These data show that miR-625 is
an important participant in the regulations of migration and inva-
sion potential of gastric cancer cells.Fig. 1. miR-625 is downregulated in gastric cancer tissues and cells. (A) qRT-PCR for mi
⁄p < 0.001. (B) qRT-PCR for miR-625 in seven gastric cancer cell lines and GES-1 cells. R3.4. Ecptopic miR-625 suppresses metastasis in nude mice
Given that miR-625 impaired migration and invasion of gastric
cancer cells in vitro, we further tested whether miR-625 could af-
fect the tumor metastasis in vivo. SGC-7901 cells with retrovirus-
mediated miR-625 stable expression (RV-miR-625) or empty vec-
tor (vector) were injected into ﬁve-week-old male nude mice
through the tail vein (Supplementary Fig. S7). The mice were
euthanized two months after the injection. The lung metastatic
nodes per mouse was much less and smaller in mice injected with
SGC-7901 cells with RV-miR-625 than that in the control group
(4.92 ± 1.89 vs 0.43 ± 0.49 metastatic nodes/mouse, P < 0.001)
(Fig. 3). Thus, these results indicate that miR-625 can suppress
metastasis of gastric cancer cells in vivo.
3.5. miR-625 inhibits the protein expression of ILK by directly targeting
30-UTR of ILK
To identify effectors of miR-625, we used TargetScan and miR-
anda algorithms to predicted the mRNA targets of miR-625 and
got numerous possible candidates. Among them, we picked out
the overexpressed in cancers and metastasis-associated genes,
including STC1, ILK, WSB1, FOXA1, NTRK3, SERBP1, DDX17 and
SPARC, for further analysis (Supplementary Fig. S8). The 30-UTRs
of these genes were cloned into the pMIR-report plasmid. The
luciferase assay showed that the activity of the reporter containing
the 30-UTR of the ILK gene was decreased by 56.9% (p = 0.002)R-625 in 54 matched human gastric cancer tissues and adjacent non-tumor tissues.
NU6B was a loading control. ⁄p < 0.05. n = 3.
Fig. 2. miR-625 regulates migration and invasion in vitro. Wound-healing assays (A), migration and invasion assays (B) after transfection with miR-625 or NC in SGC-7901
cells. Wound-healing assays (C), migration and invasion assays (D) after transfection with anti-miR-625 or anti-NC in GES-1 cells. n = 3.
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activity containing the 30-UTRs of the other genes were not obvi-
ously altered in 293T cells (Fig. 4A and 4B, Supplementary
Fig. S9). However, the inhibitory effect of miR-625 mimics was
abolished in the mutant reporter (Supplementary Fig. S10). In con-
trast, when miR-625 inhibitors were transfected, wild-type repor-
ter activity was increased in 293T cells compared with the control
(1.31 ± 0.08-fold, p = 0.008), but mutant reporter activity did not
change (Fig. 4C).
To measure the effects of miR-625 on expression levels of ILK
mRNA, qRT-PCR was performed. Neither mimics nor inhibitors of
miR-625 signiﬁcantly inﬂuenced the expression levels of ILK mRNA
(Supplementary Fig. S11). Next, we investigated whether miR-625
modulated the protein expression of ILK using immunoblots. We
observed that ILK protein levels were decreased when miR-625was restored in SGC-7901 cells. A reverse result was observed
when miR-625 was knocked down in GES-1 cells (Fig. 4D). Similar
results were observed, when miR-625 was restored in MKN-45
cells and knocked down in NCI-N87 cells (Supplementary Fig. S12).
3.6. The expression of miR-625 is inversely correlated with the
expression of ILK protein
To further conﬁrm ILK is a target of miR-625, we measured ILK
protein levels in seven gastric cancer cell lines and GES-1 cells
(Fig. 4E) and investigate the relationship between expression levels
of miR-625 and protein levels of ILK. A signiﬁcant inverse correla-
tion was observed between the expression of miR-625 and ILK pro-
tein in these cell lines (R = 0.949, p < 0.001, Fig. 4F). To detect the
levels of ILK in gastric cancer tissues, the 54 pairs of gastric cancer
Fig. 3. Ectopic expression of miR-625 inhibits metastasis in vivo. (A, B) Gross pulmonary specimens of nude mice bearing SGC-7901 metastatic tumors. (C, D) H&E stain of
SGC-7901 lung metastatic tumors. Arrows indicate metastatic foci. n = 5 per group.
Fig. 4. miR-625 inhibits the protein expression of ILK. (A) Luciferase activity in SGC-7901 cells transfected with miR-625 or NC after transfection of the indicated 30-UTR-
driven reporter constructs. n = 3. (B) The wild type and mutant complementary sequences of the ILK mRNA 30-UTR are shown with the miR-625 sequence. (C) Luciferase
activity in GES-1 cells transfected with anti-miR-625 or anti-NC. n = 3. (D) Immunoblots for ILK in the SGC-7901 cells transfected with miR-625 or NC and in the GES-1 cells
transfected with anti-miR-625 or anti-NC. GAPDH was a loading control. n = 3. (E) Immunoblots for ILK in the seven gastric cancer cell lines and GES-1 cells. GAPDH was a
loading control. (F) Correlation between miR-625 and ILK protein levels via measuring grey levels of immunoblots in gastric cancer cell lines and GES-1 cells. R = 0.949,
p < 0.001 by Spearman correlation.
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tochemistry staining. As shown in Supplementary Fig. S13, theexpression levels of ILK were higher in gastric cancer tissues than
that in GES-1 cells. Furthermore, we analyzed the relationship
Fig. 5. Knockdown of ILK inhibits cellular migration and invasion in SGC-7901 cells. (A, B) Immunoblots and qRT-PCR for ILK in the SGC-7901 cells transfected with si-ILK or
control. (C) Migration and invasion assays in SGC-7901 cells with si-ILK or control. n = 3.
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shows that miR-625 and ILK were negative correlated in gastric
cancer tissues (p = 0.017, Supplementary Fig. S14).
3.7. Knockdown of ILK inhibits cellular migration and invasion in vitro
To conﬁrm the effects of ILK on the migration and invasion of
SGC-7901 cells, ILK expression was knocked down by a ILK siRNA.
qRT-PCR and immunoblot analyses showed that the si-ILK trans-
fection of SGC-7901 cells effectively inhibited approximately
87.6% of mRNA expression and 77.9% of protein expression of
ILK, when compared to control groups (Fig. 5A, B). Consequently,
wound-healing and transwell assays examining migration and
invasion were performed. Decreased migration (3.40 ± 0.15-fold,
p = 0.002) and invasion (3.28 ± 0.20-fold, p = 0.003) cells were ob-
served in SGC-7901 cells transfected with si-ILK than the controls
(Fig. 5C). Similarly, when ILK was knocked down in MKN-45 cells
(Supplementary Fig. S15), migration and invasion cells were de-
creased (Supplementary Fig. S16). These suggest that knockdown
of ILK suppresses migration and invasion in SGC-7901 cells and
ILK is an effective target gene of miR-625.
4. Discussion
In this study, we demonstrated the inhibitory effects of miR-
625 on tumor metastasis at the clinical, animal experimental, cel-
lular and molecular four different levels. We found that miR-625
expression was down-regulated in gastric cancer and involved in
lymphnode metastasis. Restoration of miR-625 in SGC-7901 and
MKN-45 cells signiﬁcantly impaired cellular migration and inva-
sion in vitro and in vivo. In contrast, knockdown of miR-625 in
GES-1 and NCI-N87 cells reversed the effects. Screened from eight
putative genes based on bioinformatic algorithms, ILK was found
to be a target gene of miR-625. The tumor metastasis-associated
effects of ILK were consistent with the functions of miR-625 on
the phenotypes in SGC-7901 and MKN-45 cells [12–14]. Given thatILK regulates migration and invasion probably by the way of
LIMS1–ILK–parvin [15,16], we speculate that miR-625 may take
part in this pathway by regulating ILK.
Metastasis is a key step of tumor progression in gastric cancer,
which means a poor prognosis [17]. Metastasis is a series of
sequential events, including detachment, migration, local invasion,
angiogenesis, intravasation, survival in the circulatory system,
extravasation, and regrowth in different organs [18–20]. Several
miRNAs can modulate tumor metastasis [21–23]. However, the
molecular mechanisms of metastasis have not yet been fully
understood. Here, we show that miR-625 can regulated metastasis
of gastric cancer through modulating the migration and local inva-
sion at least in vitro, if not all. In vivo, we speculate that forced
miR-625 suppressed the expression of ILK and then the motility
and extravasation of SGC-7901 cells from vessels was impaired,
which contributes to reduction in lung metastasis. Further studies
based on else metastatic steps would be required to research to
fully understand the role of miR-625 in tumor metastasis.
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